Document is current
Any future updates will be listed below
-
Authors
Faia, Lisa J.
Ackert, Jessica
Rodriguez, Rachelle
Abdul Sultan, Alyshah
Garey, Colleen
Teneralli, Rachel E.
Ong, Rose
-
Funding
Funding for this research was provided by:
Johnson & Johnson
- License Information
-
More Information
Article History
Received: 20 February 2025
Accepted: 23 April 2025
First Online: 11 June 2025
Declarations
:
: Lisa J. Faia received consulting fees from Janssen and participated in speakers’ bureaus for AbbVie/Allergan, Genentech/Roche, Alimera, EyePoint, and Astellas. Jessica Ackert is a former employee of Johnson & Johnson and is currently an employee of Sanofi. Rachelle Rodriguez is a former employee of Johnson & Johnson and is currently an employee of Star Epidemiology LLC. Alyshah Abdul Sultan is a former employee of Johnson & Johnson and is currently an employee of Sanofi. Colleen Garey is an employee of Panalgo, which received funding for this analysis from Johnson & Johnson. Rachel E. Teneralli is an employee of Johnson & Johnson. Rose Ong is an employee of Actelion Pharmaceuticals, Ltd., a Johnson & Johnson Company.
: This study was based on de-identified data collected from three US health care claims databases and did not include human participants; as such, this analysis was exempt from institutional review board oversight and informed consent was not required or obtained.
